SCHEMBL3835176

SCHEMBL3835176

Nc1ccccc1NC(=O)c1ccc(CN(CCN2CCOCC2)C(=O)Nc2ccc3c(c2)OCCO3)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
LMNA P02545 4/20 0.56
TP53 P04637 2/20 0.56
POLB P06746 2/20 0.56
RAB9A P51151 1/20 0.56
HDAC1 Q13547 7/20 0.54
HDAC2 Q92769 2/20 0.52
MAPK1 P28482 2/20 0.51
NPC1 O15118 1/20 0.51
USP2 O75604 1/20 0.51
GAA P10253 3/20 0.50
THRB P10828 1/20 0.50
TSHR P16473 2/20 0.49
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506731 0.95 ALDH1A1 (0.54) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL2474439 0.93 HDAC1 (0.53) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL3835767 0.92 HDAC1 (0.56) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL2475826 0.90 HDAC1 (0.53) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL2474808 0.89 ALDH1A1 (0.54) ALDH1A1LMNAPOLBHDAC1HDAC2
SCHEMBL3836365 0.88 HDAC1 (0.54) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL4393216 0.88 HDAC1 (0.52) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL3830885 0.88 HDAC1 (0.60) ALDH1A1LMNATP53POLBRAB9A
SCHEMBL2504031 0.87 ATM (0.51) ALDH1A1LMNATP53HDAC1HDAC2
SCHEMBL13646255 0.87 HDAC1 (0.51) ALDH1A1LMNATP53POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
US-8076332-B2 N- (2-aminophenyl) benzamide derivative having urea structure SANTEN PHARMACEUTICAL CO., LTD. (JP) 2011-12-13 US disclosed
EP-2107052-B1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE SANTEN PHARMACEUTICAL CO LTD (JP) 2011-10-12 EP disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-12-10 US disclosed
EP-2107052-A1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE Santen Pharmaceutical Co., Ltd (JP) 2009-10-07 EP disclosed
EP-2107052-A1 NOVEL N-(2-AMINOPHENYL)BENZAMIDE DERIVATIVE HAVING AN UREA STRUCTURE Santen Pharmaceutical Co., Ltd (JP) 2009-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306077-A1 NOVEL N- (2-AMINOPHENYL) BENZAMIDE DERIVATIVE HAVING UREA STRUCTURE UACA, SLC14A1, ARG2 ALDH1A1 1040/4885LMNA 877/4885TP53 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.